Here is my reading/views - not an opinion for others to invest
Company has some interesting technology - they are innovators - getting into collaborations.
The path to actual success is very long - also the co has $ 1 B market cap it is fully or overvalued. For me if the market cap was in $300-400 m them there was some opportunity to make money.
In oncology space there are too many promising clinical stage co - so picking a winner is difficult - I am not sure if I should invest. I have considered and added starting position but it is like a gamble